Saturday, 31 October 2026European Markets

BARCO Stock Bullish Momentum With A 9.97% Jump Today

Loading stream...

(VIANEWS) - The Market ended the session with BARCO (BAR.BR) jumping 9.97% to €11.91 on Wednesday, following the last session's upward trend. BEL 20 jumped 0.28% to €4,017.59, after two sequential sessions in a row of losses, on what was a somewhat bullish trend trading session today.

About BARCO

Barco NV, together with its subsidiaries, develops visualization solutions for the entertainment, enterprise, and healthcare markets in the Americas, Europe, Middle East, Africa, and the Asia-Pacific. It operates through three divisions: Entertainment, Enterprise, and Healthcare. The company offers medical displays, including radiology, dental, breast imaging, surgical, clinical review, custom medical, digital pathology, and all-in-one displays; medical display controllers; healthcare software; digital operating room solutions, such as medical device management and surgical collaboration; rear-projection, LED, and LCD video walls, as well as video wall controllers; and wireless conferencing and presentation systems, as well as video bars for wireless collaboration. It also provides projection products, comprising cinema, home cinema, installation, rental, and simulation; immersive systems consisting of power walls, canvas, and caves; control room software, including Barco CTRL, SecureStream, OpSpace, and transForm N/CMS; image processing products, such as screen management and Event Master; and support, maintenance, training, and professional services. Barco NV was founded in 1934 and is headquartered in Kortrijk, Belgium.

Earnings Per Share

As for profitability, BARCO has a trailing twelve months EPS of €0.88.

PE Ratio

BARCO has a trailing twelve months price to earnings ratio of 13.53. Meaning, the purchaser of the share is investing €13.53 for every euro of annual earnings.

Volume

Today's last reported volume for BARCO is 365522 which is 110.53% above its average volume of 173616.

Volatility

BARCO's last week, last month's, and last quarter's current intraday variation average was a positive 0.52%, a negative 0.06%, and a positive 1.63%.

BARCO's highest amplitude of average volatility was 1.64% (last week), 1.34% (last month), and 1.63% (last quarter).

More news about BARCO (BAR.BR).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com